Form 8-K - Current report:
SEC Accession No. 0001104659-26-085790
Filing Date
2026-07-22
Accepted
2026-07-22 16:02:21
Documents
11
Period of Report
2026-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K crvs-20260721x8k.htm   iXBRL 8-K 33688
  Complete submission text file 0001104659-26-085790.txt   141132

Data Files

Seq Description Document Type Size
2 EX-101.SCH crvs-20260721.xsd EX-101.SCH 2693
3 EX-101.LAB crvs-20260721_lab.xml EX-101.LAB 15264
4 EX-101.PRE crvs-20260721_pre.xml EX-101.PRE 9933
14 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20260721x8k_htm.xml XML 4704
Mailing Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 261193712
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)